Search clinical trials for: Exenatide-Bayetta
Total 364 results
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SBodyMediaCompletedDiabetes Type 2United States
-
Jesper KjaergaardCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
-
Carl T. Hayden VA Medical CenterAmerican Diabetes Association; Amylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusCanada, United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Japan, Taiwan, India
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Cliniques universitaires Saint-Luc- Université...CompletedType 2 Diabetes MellitusBelgium
-
AstraZenecaEli Lilly and CompanyCompletedType 2 DiabetesBrazil, Mexico
-
University Health Network, TorontoEli Lilly and CompanyCompleted
-
AstraZenecaEli Lilly and CompanyCompletedObesityUnited States, Puerto Rico
-
University of California, DavisEli Lilly and Company; Amylin Pharmaceuticals, LLC.TerminatedDiabetes Complications | Fatty LiverUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Romania, Canada, Mexico, South Africa
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, Romania, United States, India, Puerto Rico
-
Oregon Health and Science UniversityEli Lilly and Company; Amylin Pharmaceuticals, LLC.Completed
-
University Hospital, CaenEli Lilly and CompanyUnknown
-
AstraZenecaEli Lilly and CompanyCompleted
-
Beth Israel Deaconess Medical CenterEli Lilly and Company; Amylin Pharmaceuticals, LLC.CompletedObesity | Impaired Glucose ToleranceUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly
-
AstraZenecaEli Lilly and CompanyCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited Kingdom
-
Amsterdam UMC, location VUmcBristol-Myers Squibb; Eli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes MellitusNetherlands
-
University of Alabama at BirminghamAmylin Pharmaceuticals, LLC.TerminatedType 2 Diabetes Mellitus | Bone RemodelingUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Korea, Republic of, Hungary, Canada, Australia
-
Neuroscience Trials AustraliaNational Health and Medical Research Council, Australia; Monash UniversityActive, not recruitingAcute Ischemic StrokeAustralia, Finland, New Zealand
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Taiwan, India
-
University of AarhusEli Lilly and Company; Aarhus University HospitalCompleted
-
TheracosCompletedType2 Diabetes MellitusUnited States
-
PegBio Co., Ltd.Completed
-
Kyunghee University Medical CenterCompleted
-
AstraZenecaEli Lilly and CompanyCompleted
-
National Institute of Diabetes and Digestive and...CompletedObesity | Weight LossUnited States
-
University of DundeeNewcastle-upon-Tyne Hospitals NHS Trust; Oxford University Hospitals NHS Trust and other collaboratorsCompletedDiabetesUnited Kingdom
-
Merck Sharp & Dohme LLCCompletedThe Methodology Assessment of Glucose Dependent Insulin Secretion
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedType 2 DiabetesUnited States
-
University of Maryland, BaltimoreTerminated
-
AstraZenecaEli Lilly and CompanyCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusNetherlands, Canada
-
Xiangya Hospital of Central South UniversityRecruiting
-
AstraZenecaEli Lilly and Company; i3 Drug SafetyCompletedType 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)United States
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
The University of Texas Health Science Center at...CompletedHealthy | Type 2 Diabetes | Impaired Glucose ToleranceUnited States
-
Beijing Chao Yang HospitalUnknownCoronary Endothelial Function
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States